Citicoline clinical efficiency in complex treatment of postresuscitation syndrome

The problem of global cerebral dysfunction at postresuscitation syndrome (PRS) remains topical today. Until recently for the correction of central nervous system disorders there was used, and is used by most doctors, piracetam. We had carried out the examination of 2 groups of patients (group A and B) with PRS after successful resuscitation. They were administered with Citicoline and piracetam secondary to standard set of intensive care. The use of Citicoline in intensive care of PRS was proved. The Citicoline positive influence on the level and duration of impairment of consciousness was shown as well as promotion to more progressive recovery of mental functions at PRS.